相关实验视频

Updated: Sep 15, 2025

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

ARM-X:一种可适应的基层细胞基的疫苗接种平台,适用于固体瘤

Jean Pierre Bikorimana¹, Nehme El-Hachem², Gabrielle A Mandl¹

¹Department of Microbiology, Infectious Diseases, and Immunology, Université de Montréal, 2900 Edouard-Montpetit, Montreal, QC, H3T 1J4, Canada.

Stem cell research & therapy

|July 14, 2025

概括

新型AccuTOX®平台增强了癌症疫苗接种中细胞 (MSCs),降低了抗原剂量要求. 这种第二代ARM-X疫苗通过激活抗原交叉呈现的未折叠蛋白反应 (UPR) 来有效向多个固体瘤.

科学领域:

免疫学免疫学免疫学
细胞生物学细胞生物学
在瘤学瘤学.

背景情况:

使用Accum®平台进行工程的介质细胞 (MSC) 显示了抗原交叉呈现的潜力.
第一代ARM疫苗需要高剂量的抗原才能产生治疗效果.
艾库托克斯 (AccuTOX®) 是作为一种减少抗原数量要求的变体而开发的.

研究的目的:

评估AccuTOX®重编程MSCs (ARM-X) 作为癌症疫苗的疗效.
调查AccuTOX®在MSC中的作用机制.
在各种固体瘤模型中评估ARM-X细胞的治疗潜力.

主要方法:

使用B3ZT细胞克隆的抗原交叉呈现试验.
对MSCs的内体体逃逸和抗氧化作用的分析.
在体内对有固体瘤的C57BL/6小鼠进行的研究,包括耗尽研究.
通过免疫皮组分析对人类MSCs的发现的验证.

主要成果:

阿库托克斯®使MSC能够有效地交叉呈现抗原,即使是低剂量,同时保持先天的MSC特性.
在黑色素瘤,胰腺和结肠癌模型中,ARM-X疫苗结合抗PD-1抑制瘤生长的治疗性施用.
在ARM-X疫苗的有效性取决于效细胞分裂,并需要CD4+和CD8+T细胞.

结论:

第二代ARM-X疫苗是一个多功能平台,可以适应多个固体瘤.
在AccuTOX®诱导的未折叠蛋白反应 (UPR) 激活和MSC中的抗原交叉呈现之间存在直接联系.
UPR刺激提供了一种新的策略,将MSC转化为用于各种癌症的细胞疫苗接种工具.

关键词:

在 AccuTOX® 的使用过程中,原细胞疫苗原细胞疫苗抗原交叉呈现的交叉呈现细胞内体逃脱是什么?免疫皮组是一种免疫皮组.介质细胞层细胞是介质细胞层细胞.有反应性氧物种的反应性氧物种.不折叠的蛋白质反应反应

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...